Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Mersana Therapeutics Inc (NASDAQ: MRSN) closed the day trading at $0.32 down -4.81% from the previous closing price of $0.34. In other words, the price has decreased by -$4.81 from its previous closing price. On the day, 1.94 million shares were traded.
Ratios:
For a better understanding of MRSN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.19.
JP Morgan Upgraded its Underweight to Neutral on March 19, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 16 ’25 when Mandelia Ashish sold 3,554 shares for $0.58 per share. The transaction valued at 2,061 led to the insider holds 57,519 shares of the business.
Protopapas Anna sold 8,637 shares of MRSN for $5,009 on Jan 16 ’25. The Director now owns 168,041 shares after completing the transaction at $0.58 per share. On Jan 16 ’25, another insider, Lowinger Timothy B, who serves as the SVP, Chief Sci.&Tech. Officer of the company, sold 8,048 shares for $0.58 each. As a result, the insider received 4,668 and left with 257,673 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $3.50, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is -19.33%, while the 200-Day Moving Average is calculated to be -75.45%.
Shares Statistics:
A total of 115.65M shares are outstanding, with a floating share count of 85.81M. Insiders hold about 31.15% of the company’s shares, while institutions hold 54.02% stake in the company.
